Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003147087 | SCV003833503 | uncertain significance | Hereditary spherocytosis type 5 | 2021-10-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004246140 | SCV004865629 | uncertain significance | Inborn genetic diseases | 2022-08-08 | criteria provided, single submitter | clinical testing | The c.1045C>A (p.Q349K) alteration is located in exon 7 (coding exon 7) of the EPB42 gene. This alteration results from a C to A substitution at nucleotide position 1045, causing the glutamine (Q) at amino acid position 349 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |